TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
The XBiotech stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
XBiotech, Inc. is a biopharmaceutical company, which engages in development and commercialization of therapeutic antibodies based on its True Human™ proprietary technology. Its product pipeline include oncology, infectious diseases, dermatology, and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
What was XBiotech’s price range in the past 12 months?
XBiotech lowest stock price was $15.00 and its highest was $21.48 in the past 12 months.
What is XBiotech’s market cap?
XBiotech’s market cap is $466.61M.
What is XBiotech’s price target?
Currently, no data Available
What do analysts say about XBiotech?
Not enough analysts have published a price target to provide an average price target.
When is XBiotech’s upcoming earnings report date?
XBiotech’s upcoming earnings report date is May 09, 2019 which is 2 years ago.
How were XBiotech’s earnings last quarter?
XBiotech released its earnings results on Mar 14, 2019. The company reported -$0.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.17.
Is XBiotech overvalued?
According to Wall Street analysts XBiotech’s price is currently Overvalued.
Does XBiotech pay dividends?
XBiotech pays a Notavailable dividend of $2.5 which represents an annual dividend yield of 15.55%. XBiotech’s last Notavailable dividend payment was on Jul 23, 2021. XBiotech’s upcoming ex-dividend date is Jul 15, 2021
What is XBiotech’s EPS estimate?
XBiotech’s EPS estimate is -$0.16.
How many shares outstanding does XBiotech have?
XBiotech has 30,380,000 shares outstanding.
What happened to XBiotech’s price movement after its last earnings report?
XBiotech reported an EPS of -$0.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.301%.
Which hedge fund is a major shareholder of XBiotech?
Among the largest hedge funds holding XBiotech’s share is Caxton Associates LP. It holds XBiotech’s shares valued at 171K.